Ana Carolina V S C de Araujo
Overview
Explore the profile of Ana Carolina V S C de Araujo including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
5
Citations
32
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Mambelli F, de Araujo A, Farias J, de Andrade K, Ferreira L, Minoprio P, et al.
Pathogens
. 2025 Jan;
14(1).
PMID: 39860984
The COVID-19 pandemic has posed a significant threat to global health systems, with extensive impacts across many sectors of society. The pandemic has been responsible for millions of deaths worldwide...
2.
Marinho F, Brito C, de Araujo A, Oliveira S
Front Immunol
. 2024 Feb;
15():1341464.
PMID: 38404575
Introduction: Guanylate-binding proteins (GBPs) are produced in response to pro-inflammatory signals, mainly interferons. The most studied cluster of GBPs in mice is on chromosome 3. It comprises the genes for...
3.
de Araujo A, Mambelli F, Sanches R, Marinho F, Oliveira S
Pathogens
. 2023 Dec;
12(12).
PMID: 38133271
The bacillus Calmette-Guérin (BCG) is an attenuated bacterium derived from virulent . It is the only licensed vaccine used for preventing severe forms of tuberculosis in children. Besides its specific...
4.
de Araujo A, de Queiroz N, Marinho F, Oliveira S
J Immunol
. 2023 Jul;
211(5):791-803.
PMID: 37477668
The bacillus Calmette-Guérin (BCG) can elicit enhanced innate immune responses against a wide range of infections, known as trained immunity. Brucella abortus is the causative agent of brucellosis, a debilitating...
5.
de Queiroz N, Marinho F, de Araujo A, Fahel J, Oliveira S
Sci Rep
. 2021 Aug;
11(1):15648.
PMID: 34341449
Bacillus Calmette-Guerin (BCG) is the only FDA approved first line therapy for patients with nonmuscle invasive bladder cancer. The purpose of this study is to better understand the role of...
6.
Marinho F, Fahel J, de Araujo A, Diniz L, Gomes M, Resende D, et al.
J Leukoc Biol
. 2020 Jul;
108(4):1279-1291.
PMID: 32620042
Guanylate binding proteins (GBPs) are important effector molecules of autonomous response induced by proinflammatory stimuli, mainly IFNs. The murine GBPs clustered in chromosome 3 (GBPchr3) contains the majority of human...